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f disease has been broken successfully, there remains a
rightening prospect of a future outbreak whichmay bemore
ontagious or virulent than ever encountered before.
Methods: Protein inhibitor of activated signal transducer
nd activator of transcription (STAT) 1(PIAS1) was identi-
ed in yeast two hybrid screens as an interacting partner
or STAT1. The interaction of N with PIAS1 was validated in
ammalian cells using co-immunoprecipitation.
Results: Our results of time-course based co-localisation
hows that the localization of N shifts from cytoplasmic to
uclear in presence of PIAS1. This, not only points towards
nteraction between N and PIAS1 but also one that is of major
hysiological consequence. PIAS1 acts as a key regulator of
K’B signaling pathway in the nucleus where it inhibits its
NA binding activity and NK’B mediated gene activation. NF-
B is a critical regulator of the immediate early pathogen
esponse, playing an important role in promoting inﬂamma-
ion and in the regulation of cell proliferation and survival.
ene activation analysis have shown that PIAS1 selectively
egulates a subset of NK’B dependent genes, with a notable
reference for proinﬂammatory cytokines and chemokines.
ere, we found that in presence of N, the inhibition induced
y PIAS1 to DNA binding activity of NF’B and NF’B medi-
ted gene activation is lifted. Not only that, our results
eveals that both DNA binding activity and NF’B mediated
ene activation is enhanced in presence of N.
Conclusion: We hypothesize that N translocates into
he nucleus where it, enhances the DNA binding activ-
ty of NF’B and NF’B mediated gene expression by lifting
p the inhibition imposed by PIAS1. Since many protein
roducts of the NF’B sensitive genes have been reported
o be upregulated in fatal clinical cases of SARS, we fur-
her hypothesize that N protein plays an important role in
xcessive expression/secretion of cytokines and chemokines
hereby contributing signiﬁcantly to the lung injury seen in
ases of SARS.
oi:10.1016/j.ijid.2010.02.666
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Background: Rhinovirus (Rhino) is one of the major
iruses of respiratory illness. There is a report that rhi-
oviruses had the highest prevalence among diseased cases
mong children under 5 years old who are hospitalized
y acute respiratory illness. The novel group of rhinovirus
rhino C) was found recently. However, details of epidemi-
logical features, including rhino C, in tropical climate are
till unknown. In this study, we tried to access the impor-
1
F
pternational Congress on Infectious Diseases (ICID) Abstracts
ance of rhinoviruses among severe respiratory infection of
hildren in the Philippines.
Methods: 816 nasopharyngeal swabs which were col-
ected from May 2008 to May 2009 from children (age: 7days
14years old) who were diagnosed as severe pneumonia were
sed.
RNA was extracted and subjected to RT-PCR targeting
’Non Coding Region and VP4/VP2 region. Sequencing analy-
is was carried out and rhinoviruses genogroups (A∼C) were
etermined.
Results: 243 out of 816 samples (30%) were positive for
hinoviruses. Among rhinoviruses positive samples, 131 (54%)
ere positive for rhino A, 25 (10%) were for rhino B, and
6 (35%) were for rhino C. The nucleotide sequence of Rhi-
ovirses (A,B,C) in VP4/VP2 showed that variable types of
hinovirus are co-circulating in one area, and were related
losely to the ones reported from various countries and year.
o etiological correlation was seen between any genogroups
r subspecies and severity. Rhinoviruses were detected all
he year.
However there was a peak for Rhino A in July to Septem-
er, Rhino B in September to November, and Rhino C in
ebruary to March. Rhinovirus infection in tropical zone may
ave different seasonality from the one in template zone
nd each genogroups may have different seasonality.
Conclusion: Rhinoviruses were detected with high preva-
ence among severe pneumonia which may suggest their
mportance among children in the Philippines.
oi:10.1016/j.ijid.2010.02.667
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Background: Viral diseases occupy 1-st place in infectious
athology and agents having pluripotent activity against dif-
erent viruses are welcomed. Previously, it was found that
errovir (FV) (sodium salt of DNA from salmon’s milt con-
ugated with Fe3+) possess antiviral activity against DNA-
nd RNA-viruses with lipid membrane: Herpes Simplex Virus
HSV), Cytomegalovirus (CMV), Human Immunodeﬁciency
irus (HIV), Tick-borne encephalitis virus, Human and Avian
nﬂuenza Virus in vitro studies. The mechanism of FV action
s connected with induction of inﬂammation cytokines and
ligopeptide antiviral factors. FV was effective in immuno-
ompromised patients (pts) with HIV-infection and Hepatitis
infection. The aim of the study was to analyze the efﬁ-
iency of FV against HSV-, CMV- and Human Papillomavirus
nfection (PVI).Methods: Clinical study enrolled 29 pts (15 female and
4 male) with recurrent genital HSVinfection who received
V 75mg once in 2 days as i/m injection for 20 days and 30
ts received standard therapy. Group of 11 pts (female) with
